Phase I Clinical Trial of Everolimus Combined with Trimodality Therapy in Patients with Muscle-Invasive Bladder Cancer

Background: Local control following trimodality therapy (TMT) for muscle-invasive bladder cancer (MIBC) requires further optimization. Objective: Evaluating the biologic endpoint, feasibility, and toxicity of integrating everolimus to TMT in patients with MIBC. Methods: This was a phase I trial in p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Bladder Cancer
Main Authors: Bachir, Bassel G., Souhami, Luis, Mansure, Jose João, Cury, Fabio, Vanhuyse, Marie, Brimo, Fadi, Aprikian, Armen G., Tanguay, Simon, Sturgeon, Jeremy, Kassouf, Wassim
Formato: Artigo
Idioma:Inglês
Publicado em: IOS Press 2017
Assuntos:
Research Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5409045/
https://ncbi.nlm.nih.gov/pubmed/28516155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/BLC-160090
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados